Substance use & addiction testing
Substance use and addiction are continuing to rise.
In addition to Fentanyl causing a crisis, Xylazine "Tranq" is here.
Practitioners are harried.
Patients are in pain.
The stakes are high.
It is why we are using the most advanced science and testing we can offer.
What is Xylazine?
Xylazine, also known as “tranq or tranq dope,” is a non-opioid sedative or tranquilizer approved only in veterinary medicine as a sedative with analgesic and muscle relaxant properties. Illegal drugs such as cocaine, heroin, and fentanyl can be mixed with xylazine to extend the duration of drug effects or expand street value. Drug users who use illegal drugs may not be aware of its presence, and because xylazine is a sedative and not an opioid, it resists standard opioid overdose reversal treatments.
Xylazine/Fentanyl Crisis Useful Information:
- FDA National Response Plan
- Warnings from FDA
- DEA Growing Threat of Xylazine and its mixture to illicit drugs
The Acutis Difference
Our promise to you
Your results are delivered rapidly, in as few as 24 hours, allowing you to act fast and intervene immediately if needed
Sharper cut-off values identify substances too often missed by ordinary testing, allowing you to provide the best care for your patients
Our advanced testing and practices conform to the payor, industry, and regulatory compliance protects your practice
To ensure the greatest degree of accuracy, our advanced screening with LC-MS/MS technology ensures substances aren’t missed due to high cutoff values and low cross-reactivity in the screening.
Start testing with Acutis
If you want to know more about our substance use & addiction testing
While our menu of testing options is continually refined to meet today’s clinical requirements, our commitment to innovation promises ever more accurate results.You can always email or call Acutis and speak directly with one of our sales specialists to learn more.